Cited by 134Liver Disease Diagnosis and TreatmentLiver physiology and pathologyAlcohol Consumption and Health Effects

The DOI matches its Crossref record; 123 of the 123 references it cites were found in a registry or an index.

Nonalcoholic fatty liver disease: a challenge from mechanisms to therapy.

Open access

Tarantino, Giovanni, Citro, Vincenzo, Capone, Domenico·2019·Journal of Clinical Medicine

DOI 10.3390/jcm9010015PMC PMC7019297

Open this paper in CoChat — free account Open PDF

Abstract

Focusing on previously published mechanisms of non-alcoholic fatty liver disease (NAFLD), their uncertainty does not always permit a clear elucidation of the grassroot alterations that are at the basis of the wide-spread illness, and thus curing it is still a challenge. There is somehow exceptional progress, but many controversies persist in NAFLD research and clinical investigation. It is likely that hidden mechanisms will be brought to light in the near future. Hereby, the authors present, with some criticism, classical mechanisms that stand at the basis of NAFLD, and consider contextually different emerging processes. Without ascertaining these complex interactions, investigators have a long way left ahead before finding an effective therapy for NAFLD beyond diet and exercise.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.3390/jcm9010015

Cites

123 of 123 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Structure, function and diversity of the healthy human microbiome
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11234 · Cited by 11,726
Increased oxidative stress in obesity and its impact on metabolic syndrome
Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., Nakayama, O., Makishima, M., Matsuda, M., & Shimomura, I. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21625 · Cited by 5,508
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
A central role for JNK in obesity and insulin resistance
Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., Karin, M., & Hotamisligil, G. S. (2002) · Nature · doi:10.1038/nature01137 · Cited by 3,359
The gut flora as a forgotten organ
O'Hara, A. M., & Shanahan, F. (2006) · The EMBO Reports · doi:10.1038/sj.embor.7400731 · Cited by 2,791
Mechanisms for Insulin Resistance: Common Threads and Missing Links
Samuel, V. T., & Shulman, G. I. (2012) · Cell · doi:10.1016/j.cell.2012.02.017 · Cited by 2,294
Extensive impact of non-antibiotic drugs on human gut bacteria
Maier, L., Pruteanu, M., Kuhn, M., Zeller, G., Telzerow, A., Anderson, E. E., Brochado, A. R., Fernandez, K. C., Dose, H., Mori, H., et al. (2018) · Nature · doi:10.1038/nature25979 · Cited by 1,905
Genetics of the Evolutionary Process.
Dobzhansky, T. (1970) · doi:10.5281/zenodo.10742832 · Cited by 1,617
The crucial role of protein phosphorylation in cell signaling and its use as targeted therapy (Review)
Ardito, F., Giuliani, M., PERRONE, D., Troiano, G., & Muzio, L. L. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.3036 · Cited by 1,437
High-Throughput Sequencing Technologies
Reuter, J., Spacek, D. V., & Snyder, M. P. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.05.004 · Cited by 1,404

Flagged first, then by citations

Show all 123 references

Sorted by citations

A review on COVID-19 forecasting models
Rahimi, I., Fang, C., & Gandomi, A. H. (2021) · Neural Computing and Applications · doi:10.1007/s00521-020-05626-8 · Cited by 298
Mutual interaction between endoplasmic reticulum and mitochondria in nonalcoholic fatty liver disease
Wang, J., He, W., Tsai, P.-J., Chen, P.-H., Ye, M., Guo, J., & Su, Z. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01210-0 · Cited by 158
Effect of Exercise Training on Fat Loss—Energetic Perspectives and the Role of Improved Adipose Tissue Function and Body Fat Distribution
Kolnes, K. J., Petersen, M. H., Lien-Iversen, T., Højlund, K., & Jensen, J. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.737709 · Cited by 112
New Insights in Mechanisms and Therapeutics for Short- and Long-Term Impacts of Hepatic Ischemia Reperfusion Injury Post Liver Transplantation
Liu, H., & Man, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158210 · Cited by 110
Liver-spleen axis in nonalcoholic fatty liver disease
Tarantino, G., Citro, V., & Balsano, C. (2021) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2021.1914587 · Cited by 107
Silymarin: Unveiling its pharmacological spectrum and therapeutic potential in liver diseases—A comprehensive narrative review
Jaffar, H. M., Al‐Asmari, F., Khan, F. A., Rahim, M. A., & Zongo, E. (2024) · Food Science & Nutrition · doi:10.1002/fsn3.4010 · Cited by 108
It Is High Time Physicians Thought of Natural Products for Alleviating NAFLD. Is There Sufficient Evidence to Use Them?
Tarantino, G., Balsano, C., Santini, S. J., Brienza, G., Clemente, I., Cosimini, B., & Sinatti, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413424 · Cited by 90
Effect of Intermittent Fasting on Non-Alcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis
Yin, C., Li, Z., Xiang, Y., Peng, H., Yang, P. C., Yuan, S., Zhang, X., Wu, Y., Huang, M., & Li, J. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.709683 · Cited by 74
Apple Polyphenol Extract Improves High-Fat Diet-Induced Hepatic Steatosis by Regulating Bile Acid Synthesis and Gut Microbiota in C57BL/6 Male Mice
Li, D., Cui, Y., Wang, X., Liu, F., & Li, X. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c02532 · Cited by 72
Does moderate alcohol consumption accelerate the progression of liver disease in NAFLD? A systematic review and narrative synthesis
Jarvis, H., O'Keefe, H., Craig, D., Stow, D., Hanratty, B., & Anstee, Q. M. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-049767 · Cited by 71
Sleep Duration, Sleep Quality, and the Development of Nonalcoholic Fatty Liver Disease: A Cohort Study
Um, Y. J., Chang, Y., Jung, H. S., Cho, I. Y., Shin, J. H., Shin, H. C., Wild, S. H., Byrne, C. D., & Ryu, S. (2021) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000417 · Cited by 63
Biogenic Phytochemicals Modulating Obesity: From Molecular Mechanism to Preventive and Therapeutic Approaches
Kumar, V., Singh, D. D., Lakhawat, S. S., Yasmeen, N., Pandey, A., & Singla, R. K. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/6852276 · Cited by 64
Association Between SARS-CoV-2 Cycle Threshold Values and Clinical Outcomes in Patients With COVID-19: A Systematic Review and Meta-analysis
Shah, V. P., Farah, W. H., Hill, J. C., Hassett, L. C., Binnicker, M. J., Yao, J. D. C., & Murad, M. H. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab453 · Cited by 52
Prevalence and characteristics of MAFLD in Chinese adults aged 40 years or older: A community-based study
Zeng, J., Qin, L., Jin, Q., Yang, R., Ning, G., Su, Q., YANG, Z. K., & Fan, J. (2022) · Hepatobiliary & pancreatic diseases international · doi:10.1016/j.hbpd.2022.01.006 · Cited by 55
Coffee Consumption and Non-alcoholic Fatty Liver Disease: An Umbrella Review and a Systematic Review and Meta-analysis
Kositamongkol, C., Kanchanasurakit, S., Auttamalang, C., Inchai, N., Kabkaew, T., Kitpark, S., Chaiyakunapruk, N., Duangjai, A., Saokaew, S., & Phisalprapa, P. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.786596 · Cited by 50
Natural PPARs agonists for the treatment of nonalcoholic fatty liver disease
Pan, J., Zhou, W., Xu, R., Xing, L., Ji, G., & Dang, Y. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113127 · Cited by 50
Acute Myocardial Infarction Biosensor: A Review From Bottom Up
Reyes-Retana, J. A., & Duque-Ossa, L. C. (2020) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2020.100739 · Cited by 51
Effects of dietary thyme essential oil on blood haematobiochemical, redox status, immunological and reproductive variables of rabbit does exposed to high environmental temperature
Abdelnour, S. A., El-Ratel, I. T., Peris, S. I., El‐Raghi, A. A., & Fouda, S. F. (2022) · Italian Journal of Animal Science · doi:10.1080/1828051x.2021.2006807 · Cited by 49
Associations Between GGT/HDL and MAFLD: A Cross-Sectional Study
Xing, Y., Chen, J., Liu, J., & Ma, H. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s342505 · Cited by 49
The Impact of Dysmetabolic Sarcopenia Among Insulin Sensitive Tissues: A Narrative Review
Armandi, A., Rosso, C., Caviglia, G. P., Ribaldone, D. G., & Bugianesi, E. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.716533 · Cited by 48
A Brief Overview of Oxidative Stress in Adipose Tissue with a Therapeutic Approach to Taking Antioxidant Supplements
Taherkhani, S., Suzuki, K., & Ruhee, R. T. (2021) · Antioxidants · doi:10.3390/antiox10040594 · Cited by 52
Hepatopathy Associated With Type 1 Diabetes: Distinguishing Non-alcoholic Fatty Liver Disease From Glycogenic Hepatopathy
Mertens, J., Block, C. E. M. D., Spinhoven, M. J., Driessen, A. L. C., Francque, S., & Kwanten, W. J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.768576 · Cited by 48
Neurogenic hypothesis of positive psychology in stress-induced depression: Adult hippocampal neurogenesis, neuroinflammation, and stress resilience
Wu, Z., Xiao, L., Wang, H., & Wang, G. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107653 · Cited by 48
Liver-related Mortality is Increased in Lean Subjects with Non- alcoholic Fatty Liver Disease Compared to Overweight and Obese Subjects
Feldman, A., Wernly, B., Strebinger, G., Eder, S. K., Zandanell, S., Niederseer, D., Straßer, M., Haufe, H., Sotlar, K., Paulweber, B., et al. (2021) · Journal of Gastrointestinal and Liver Diseases · doi:10.15403/jgld-3622 · Cited by 46
Hypoxia-Inducible Factors as Key Players in the Pathogenesis of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis
Holzner, L. M. W., & Murray, A. J. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.753268 · Cited by 45
FABP4 in LSECs promotes CXCL10-mediated macrophage recruitment and M1 polarization during NAFLD progression
Zhou, C., Shen, Z., Shen, B., Dai, W., Sun, Z., Guo, Y., Xu, X., Wang, J., Lu, J., Zhang, Q., et al. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166810 · Cited by 45
The Role of Phytosterols in Nonalcoholic Fatty Liver Disease
Frăsinariu, O. E., Șerban, R., Trandafir, L. M., Miron, I. C., Stârcea, I. M., Vasiliu, I., Alisi, A., & Temneanu, O. R. (2022) · Nutrients · doi:10.3390/nu14112187 · Cited by 44
Characterization of Gut Microbiome in Korean Patients with Metabolic Associated Fatty Liver Disease
Oh, J. H., Lee, J., Cho, M. S., Kim, H., Chun, J., Lee, J. H., Yoon, Y., & Kang, W. (2021) · Nutrients · doi:10.3390/nu13031013 · Cited by 43
Multi-Pharmacology of Berberine in Atherosclerosis and Metabolic Diseases: Potential Contribution of Gut Microbiota
Yang, S., Li, D., Yu, Z., Li, Y., & Wu, M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.709629 · Cited by 40
Probiotic-Induced Tolerogenic Dendritic Cells: A Novel Therapy for Inflammatory Bowel Disease?
Ghavami, S. B., Aghdaei, H. A., Sorrentino, D. R., Shahrokh, S., Farmani, M., Ashrafian, F., Dore, M. P., Raftar, S. K. A., Khoramjoo, S. M., & Zali, M. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158274 · Cited by 41
Ginsenoside Rk3 Regulates Nonalcoholic Steatohepatitis by Modulation of Intestinal Flora and the PI3K/AKT Signaling Pathway in C57BL/6 Mice
Guo, M., Zhu, C., Fu, R., Ma, X., Duan, Z., & Fan, D. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.3c00789 · Cited by 38
The impacts of vitamin D supplementation in adults with metabolic syndrome: A systematic review and meta-analysis of randomized controlled trials
Qi, K.-J., Zhao, Z.-T., Zhang, W., & Yang, F. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1033026 · Cited by 65
Molecular Imaging of Brown Adipose Tissue Mass
Yang, J., Zhang, H., Parhat, K., Xu, H. X., Li, M., Wang, X., & Ran, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179436 · Cited by 40
An update on drug development for the treatment of nonalcoholic fatty liver disease – from ongoing clinical trials to future therapy
Rau, M., & Geier, A. (2021) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2021.1884068 · Cited by 37
Similarities and Differences: A Comparative Review of the Molecular Mechanisms and Effectors of NAFLD and AFLD
Zhang, P., Wang, W., Mao, M., Gao, R., Shi, W., Li, D., Calderone, R., Sui, B., Tian, X., & Meng, X. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.710285 · Cited by 38
Partially hydrolyzed guar gum attenuates non-alcoholic fatty liver disease in mice through the gut-liver axis
Takayama, S., Katada, K., Takagi, T., Iida, T., Ueda, T., Mizushima, K., Higashimura, Y., Morita, M., Okayama, T., Kamada, K., et al. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i18.2160 · Cited by 34
A potential link between plasma short‑chain fatty acids, TNF‑α level and disease progression in non‑alcoholic fatty liver disease: A retrospective study
Xiong, J., Chen, X., Zhao, Z., Liao, Y., Zhou, T., & Xiang, Q. (2022) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2022.11536 · Cited by 36
Effect of LncPVT1/miR-20a-5p on Lipid Metabolism and Insulin Resistance in NAFLD
Zhang, H., Niu, Q., Liang, K., Li, X., Jiang, J., & Bian, C. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s338097 · Cited by 33
Resveratrol prevents liver damage in MCD-induced steatohepatitis mice by promoting SIGIRR gene transcription
Che, Y., Shi, X., Zhong, X., Zhang, Y., Si, R., Li, Y., & Shi, Y. (2020) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2020.108400 · Cited by 31
SR-B1, a Key Receptor Involved in the Progression of Cardiovascular Disease: A Perspective from Mice and Human Genetic Studies
Gracia‐Rubio, I., Martı́n, C., Civeira, F., & Cenarro, A. (2021) · Biomedicines · doi:10.3390/biomedicines9060612 · Cited by 32
Comparison of several blood lipid-related indexes in the screening of non-alcoholic fatty liver disease in women: a cross-sectional study in the Pearl River Delta region of southern China
Wang, J., Su, Z., Feng, Y.-J., Xi, R., Liu, J., & Wang, P. (2021) · BMC Gastroenterology · doi:10.1186/s12876-021-02072-1 · Cited by 31
Effects of Synbiotics, Probiotics, and Prebiotics on Liver Enzymes of Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Network Meta-Analysis
Kanchanasurakit, S., Kositamongkol, C., Lanoi, K., Nunta, M., Saetuan, T., Chaiyakunapruk, N., Saokaew, S., & Phisalprapa, P. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.880014 · Cited by 31
Overview of Cellular and Soluble Mediators in Systemic Inflammation Associated with Non-Alcoholic Fatty Liver Disease
Marqués, P., Francisco, V., Martínez‐Arenas, L., Carvalho‐Gomes, Â., Domingo, E., Piqueras, L., Berenguer, M., & Sanz, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032313 · Cited by 31
Understanding the Changing Landscape of Health Disparities in Chronic Liver Diseases and Liver Cancer
Herren, O. M., Gillman, A. S., Marshall, V. J., & Das, R. (2022) · Gastro Hep Advances · doi:10.1016/j.gastha.2022.12.001 · Cited by 29
The Role of TLRs in Obesity and Its Related Metabolic Disorders
Campos-Bayardo, T. I., Román-Rojas, D., García-Sánchez, A., Cardona-Muñóz, E. G., Sánchez-Lozano, D. I., Totsuka-Sutto, S. E., Gómez-Hermosillo, L. F., Casillas-Moreno, J., Sierra, J. A., Pazarín–Villaseñor, L., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26052229 · Cited by 36
Future perspectives in diabesity treatment: Semaglutide, a glucagon‑like peptide 1 receptor agonist (Review)
Tilinca, M. C., Tiucă, R. A., Niculas, C., Varga, A., & Ţilea, I. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10601 · Cited by 30
Chronic exposure to Pb2+ perturbs Ch REBP transactivation and coerces hepatic dyslipidemia
Daniel, P. V., Kamthan, M., Gera, R., Dogra, S., Gautam, K., Ghosh, D., & Mondal, P. (2019) · FEBS Letters · doi:10.1002/1873-3468.13538 · Cited by 28
Hepatoprotection of capsaicin in alcoholic and non-alcoholic fatty liver diseases
Karimi‐Sales, E., Mohaddes, G., & Alipour, M. R. (2021) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2021.1962913 · Cited by 28
Toll-like receptor 1 as a possible target in non-alcoholic fatty liver disease
Baumann, A., Nier, A., Hernández-Arriaga, A. M., Brandt, A., Pisarello, M. J. L., Jin, C. J., Pilar, E., Camarinha‐Silva, A., Schattenberg, J. M., & Bergheim, I. (2021) · Scientific Reports · doi:10.1038/s41598-021-97346-9 · Cited by 28
How do probiotics alleviate constipation? A narrative review of mechanisms
Huang, Y.-P., Shi, J.-Y., Luo, X.-T., Luo, S.-C., Cheung, P. C. K., Corke, H., Yang, Q.-Q., & Zhang, B. (2024) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2024.2336531 · Cited by 28
Dexmedetomidine alleviates neuroinflammation, restores sleep disorders and neurobehavioral abnormalities in rats with minimal hepatic encephalopathy
Zhang, Y., Tan, S.-L., Du, J., Chen, Y., Jia, J., Feng, J., Liu, K., & Zhou, J. F. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107795 · Cited by 25
The rs599839 A>G Variant Disentangles Cardiovascular Risk and Hepatocellular Carcinoma in NAFLD Patients
Meroni, M., Longo, M., Paolini, E., Alisi, A., Miele, L., Caro, E. R. D., Pisano, G., Maggioni, M., Soardo, G., Valenti, L. V. C., et al. (2021) · Cancers · doi:10.3390/cancers13081783 · Cited by 24
The Homocysteine and Metabolic Syndrome: A Mendelian Randomization Study
Lee, H., In, S., & Park, T. (2021) · Nutrients · doi:10.3390/nu13072440 · Cited by 24
Postoperative ratio of C-reactive protein to albumin is an independent prognostic factor for gastric cancer
Li, C., Yang, X., Li, H., Fu, Y., Wang, W., Jin, X., Bian, L., Zhao, H., Li, D., Gao, J., et al. (2023) · European journal of medical research · doi:10.1186/s40001-023-01334-w · Cited by 24
Adipose tissue and age‑dependent insulin resistance: New insights into WAT browning (Review)
Wu, C., Yu, P., & Sun, R. (2021) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2021.4904 · Cited by 25
(−)-Syringaresinol suppressed LPS-induced microglia activation via downregulation of NF-κB p65 signaling and interaction with ERβ
Zhang, L., Jiang, X., Zhang, J., Gao, H., Yang, L., Li, D., Zhang, Q., Wang, B., Cui, L., & Wang, X. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107986 · Cited by 24
Gallstone disease and nonalcoholic fatty liver disease in patients with type 2 diabetes: a cross-sectional study
Lu, Y., Hu, L., Song, J., Wan, J., Chen, H., & Yin, J. (2021) · BMC Endocrine Disorders · doi:10.1186/s12902-021-00899-z · Cited by 23
Ectodysplasin A Is Increased in Non-Alcoholic Fatty Liver Disease, But Is Not Associated With Type 2 Diabetes
Bayliss, J. A., Ooi, G., Nardo, W. D., Johari, Y., Montgomery, M. K., McLean, C., Kemp, W. W., Roberts, S. K., Brown, W. A., Burton, P. R., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.642432 · Cited by 21
Arctigenin attenuates CCl4-induced hepatotoxicity through suppressing matrix metalloproteinase-2 and oxidative stress
Kanawati, G. M., Al-Khateeb, I. H., & Kandil, Y. I. (2021) · Egyptian Liver Journal · doi:10.1186/s43066-020-00072-6 · Cited by 21
Dulaglutide Ameliorates Palmitic Acid-Induced Hepatic Steatosis by Activating FAM3A Signaling Pathway
Lee, J., Hong, S.-W., Kim, M.-J., Moon, S. J., Kwon, H., Park, S. E., Rhee, E.-J., & Lee, W.-Y. (2022) · Endocrinology and Metabolism · doi:10.3803/enm.2021.1293 · Cited by 20
Changes in Lipidomics, Metabolomics, and the Gut Microbiota in CDAA-Induced NAFLD Mice after Polyene Phosphatidylcholine Treatment
Zhang, J., Zang, X., Lv, J., Zhang, Y., Lv, Z., & Yu, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021502 · Cited by 20
Effects of riboflavin deficiency and high dietary fat on hepatic lipid accumulation: a synergetic action in the development of non-alcoholic fatty liver disease
Wang, Y., Bian, X., Wan, M., Dong, W., Gao, W., Yao, Z., & Guo, C. (2024) · Nutrition & Metabolism · doi:10.1186/s12986-023-00775-8 · Cited by 20
Is There a Link between Basal Metabolic Rate, Spleen Volume and Hepatic Growth Factor Levels in Patients with Obesity-Related NAFLD?
Tarantino, G., Citro, V., Conforti, P., Balsano, C., & Capone, D. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8101510 · Cited by 18
LncPRYP4-3 serves as a novel diagnostic biomarker for dissecting subtypes of metabolic associated fatty liver disease by targeting RPS4Y2
Yang, H., Li, Q., Zhang, L., Zhu, M. J., Niu, J., Xue, F., Yang, L., Qu, Q., Lao, Y., Ding, Z., et al. (2020) · Clinical and Experimental Medicine · doi:10.1007/s10238-020-00636-1 · Cited by 18
Nutritional Status and Feeding Regimen of Patients with Esophagus Cancer—A Study from Vietnam
Van, B. P., Thanh, H. N. T., Le, H. T., Nguyen, A. T., Thu, H. D. T., & Viet, D. D. (2021) · Healthcare · doi:10.3390/healthcare9030289 · Cited by 23
The effect of an orally‐dosed Gynostemma pentaphyllum extract (ActivAMP®) on body composition in overweight, adult men and women: A double‐blind, randomised, placebo‐controlled study
Rao, A., Clayton, P., & Briskey, D. R. (2021) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.12936 · Cited by 17
Gender-specific prevalence of metabolic-associated fatty liver disease among government employees in Tianjin, China: a cross-sectional study
Huang, Y., Zhang, S., Zhang, M., Wang, Y., Wang, W.-H., Li, J., Li, C., & Lin, J. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-056260 · Cited by 18
The Influence of Increased Prepregnancy Body Mass Index and Excessive Gestational Weight Gain on Pregnancy Course and Fetal and Maternal Perinatal Outcomes
Lacković, M., Filimonović, D., Mihajlovic, S., Miličić, B., Filipović, I., Rovčanin, M., Dimitrijevic, D., & Nikolić, D. (2020) · Healthcare · doi:10.3390/healthcare8040362 · Cited by 19
Myostatin and Follistatin—New Kids on the Block in the Diagnosis of Sarcopenia in IBD and Possible Therapeutic Implications
Skrzypczak, D., Skrzypczak-Zielińska, M., Ratajczak, A. E., Szymczak‐Tomczak, A., Eder, P., Słomski, R., Dobrowolska, A., & Krela‐Kaźmierczak, I. (2021) · Biomedicines · doi:10.3390/biomedicines9101301 · Cited by 17
A soy glycinin derived octapeptide protects against MCD diet induced non-alcoholic fatty liver disease in mice
Ma, P., Huang, R., & Ou, Y. (2022) · Food Science and Human Wellness · doi:10.1016/j.fshw.2022.06.012 · Cited by 16
Antifibrotic effects of bezafibrate and pioglitazone against thioacetamide-induced liver fibrosis in albino rats
Ibrahim, S. A., Mohamed, M. Z., El‐Tahawy, N. F. G., & Abdelrahman, A. M. (2020) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2020-0159 · Cited by 15
Involvement of kindlin‐2 in irisin’s protection against ischaemia reperfusion‐induced liver injury in high‐fat diet‐fed mice
Jia, Z., Ren, Y., Bi, J., Wang, M., Zhang, L., Wang, T., Wei, S., Mou, X., Lv, Y., & Wu, R. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15910 · Cited by 15
Genetic Polymorphism of Vitamin D Family Genes CYP2R1, CYP24A1, and CYP27B1 Are Associated With a High Risk of Non-alcoholic Fatty Liver Disease: A Case-Control Study
Wang, M., Zhang, R., Wang, M., Zhang, L., Ding, Y., Tang, Z., Wang, H., Zhang, W., Chen, Y., & Wang, J. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.717533 · Cited by 14
Bentong ginger oleoresin mitigates liver injury and modulates gut microbiota in mouse with nonalcoholic fatty liver disease induced by high‐fat diet
Wang, K., Li, B., Fu, R., Jiang, Z., Wen, X., & Ni, Y. (2022) · Journal of Food Science · doi:10.1111/1750-3841.16076 · Cited by 14
Does NAFLD mediate the relationship between obesity and type 2 diabetes risk? evidence from the multi-ethnic study of atherosclerosis (MESA)
Rodríguez, L. A., Kanaya, A. M., SHIBOSKI, S. C., Fernández, A., Herrington, D. M., Ding, J., & Bradshaw, P. T. (2021) · Annals of Epidemiology · doi:10.1016/j.annepidem.2021.07.005 · Cited by 15
Cold-Pressed Sacha Inchi Oil: High in Omega-3 and Prevents Fat Accumulation in the Liver
Samrit, T., Osotprasit, S., Chaiwichien, A., Suksomboon, P., Chansap, S., Athipornchai, A., Changklungmoa, N., & Kueakhai, P. (2024) · Pharmaceuticals · doi:10.3390/ph17020220 · Cited by 14
Thymus atlanticus polyphenol-rich extract regulates cholesterol metabolism by inhibiting its biosynthesis without affecting its excretion in hamsters fed a high-fat diet
Ramchoun, M., Khouya, T., Alibrahim, E. A., Hmidani, A., Sellam, K., Amrani, S., Harnafi, H., Benlyas, M., Kasbi-Chadli, F., Ouguerram, K., et al. (2020) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2020.1854308 · Cited by 13
Independent associations of thyroid-related hormones with hepatic steatosis and insulin resistance in euthyroid overweight/obese Chinese adults
Ma, D., Zeng, J., Huang, B., Yan, F., Ye, J., Chen, Y., Zeng, X., Zheng, X. S., Xiao, F., Lin, M., et al. (2021) · BMC Gastroenterology · doi:10.1186/s12876-021-02011-0 · Cited by 13
Qinggan Huoxue Recipe Alleviates Alcoholic Liver Injury by Suppressing Endoplasmic Reticulum Stress Through LXR-LPCAT3
Lu, Y., Shao, M., Xiang, H., Wang, J., Ji, G., & Wu, T. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.824185 · Cited by 13
Validation model of fibrosis-8 index score to predict significant fibrosis among patients with nonalcoholic fatty liver disease
Prasoppokakorn, T., Chan, W., Wong, V. W., Pitisuttithum, P., Mahadeva, S., Mustapha, N. R. N., Wong, G. L., Leung, H. H. W., Sripongpun, P., & Treeprasertsuk, S. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i15.1563 · Cited by 13
Regulation of the PTEN/PI3K/AKT pathway in RCC using the active compounds of natural products in vitro
Wang, X. B., Xie, Z., Lou, Z., Chen, Y., Huang, S., Ren, Y., Weng, G., & Zhang, S. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.12406 · Cited by 12
PNPLA3 rs738409 C>G Variant Influences the Association Between Visceral Fat and Significant Fibrosis in Biopsy-proven Nonalcoholic Fatty Liver Disease
Li, G., Tang, L., Zhu, P., Huang, O., Rios, R. S., Zheng, K. I., Chen, S., Ma, H., Targher, G., Byrne, C. D., et al. (2021) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2021.00286 · Cited by 14
Clinical verification of the relationship between serum lipid metabolism and immune activity in breast cancer patients treated with neoadjuvant chemotherapy
Goto, W., Kashiwagi, S., Takada, K., Asano, Y., Ogisawa, K., Morisaki, T., Shibutani, M., Tanaka, H., & Maeda, K. (2023) · European journal of medical research · doi:10.1186/s40001-022-00964-w · Cited by 12
Generation of a Novel Transgenic Zebrafish for Studying Adipocyte Development and Metabolic Control
Mao, Y., Hong, K., Liao, W., Li, L., Kim, S., Xiong, Y., Nam, I.-K., Choe, S., & Kwak, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083994 · Cited by 11
The efficacy of novel metabolic targeted agents and natural plant drugs for nonalcoholic fatty liver disease treatment
Zhou, J., Chen, Y., Yu, J., Li, T., Lu, Z., Chen, Y., Zhang, X., & Ye, F. (2021) · Medicine · doi:10.1097/md.0000000000024884 · Cited by 11
Morphofunctional State and Circadian Rhythms of the Liver under the Influence of Chronic Alcohol Intoxication and Constant Lighting
Kozlova, M. A., Kirillov, Y. A., Makartseva, L. A., Chernov, I. A., & Areshidze, D. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222313007 · Cited by 11
Associations between aflatoxin B1 ‐albumin adduct levels with metabolic conditions in Guatemala: A cross‐sectional study
Álvarez, C. S., Rivera‐Andrade, A., Kroker-Lobos, M. F., Florio, A. A., Smith, J. W., Egner, P. A., Freedman, N. D., Lazo, M., Güallar, E., Dean, M. C., et al. (2022) · Health Science Reports · doi:10.1002/hsr2.495 · Cited by 10
Docosahexaenoic acid‐acylated astaxanthin monoester ameliorates chronic high‐fat diet‐induced autophagy dysfunction via ULK1 pathway in the hypothalamus of mice
Wang, X., Cong, P., Wang, X., Wang, Z., Liu, B., Xue, C., & Xu, J. (2023) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.12429 · Cited by 10
A low follicle-stimulating hormone level is a protective factor for non-alcoholic fatty liver disease in older men aged over 80
Zhu, Y., Xu, J., Zhang, X., Ke, Y., Fu, G., & Guo, Q. (2021) · BMC Geriatrics · doi:10.1186/s12877-021-02490-6 · Cited by 10
Steatosis, Steatohepatitis and Cancer Immunotherapy: An Intricate Story
Cataldi, M., Manco, F., & Tarantino, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312947 · Cited by 9
Recent insights of the role and signalling pathways of interleukin-34 in liver diseases
Al‐Shaebi, F., Liang, W., Hezam, K., Almezgagi, M., & Wei, L. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107023 · Cited by 9
β-patchoulene protects against non-alcoholic steatohepatitis via interrupting the vicious circle among oxidative stress, histanoxia and lipid accumulation in rats
Luo, H., Xu, N., Wu, J., Gan, Y., Chen, L., Guan, F., Li, M., Li, Y., Chen, J., Su, Z., et al. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107915 · Cited by 9
Ellagic Acid Modulates Necroptosis, Autophagy, Inflammations, and Stress to Ameliorate Nonalcoholic Liver Fatty Disease in a Rat Model
Li, Z., Li, J., He, S., Chen, J., Deng, C., & Duan, J.-T. (2025) · Food Science & Nutrition · doi:10.1002/fsn3.4694 · Cited by 8
Transgenerational Effects of Traumatic Historical Events on the Incidence of Metabolic Syndrome/ Nonalcoholic Fatty Liver Disease in the Romanian Population
Stoica, V., Gârdan, D. A., Constantinescu, I., Gârdan, I. P., Calenic, B., & Diculescu, M. (2020) · Journal of Medicine and Life · doi:10.25122/jml-2020-0156 · Cited by 8
TNFSF14-Derived Molecules as a Novel Treatment for Obesity and Type 2 Diabetes
Agostino, M., Rooney, J. K., Herat, L. Y., Matthews, J. R., Simonds, A., Northfield, S. E., Hopper, D., Schlaich, M. P., & Matthews, V. B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910647 · Cited by 8
C1q Tumor Necrosis Factor–Related Protein 1: A Promising Therapeutic Target for Atherosclerosis
Zhang, Z.-Z., Wang, G., Yin, S.-H., & Yu, X.-H. (2021) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001186 · Cited by 7
Effects of triglyceride and ethyl ester forms of EPA on hepatic lipid metabolism in mice with non-alcoholic fatty liver disease
Feng, J., Wang, S., Chen, F., Zhang, J., Wang, Q., Jiang, L., Wang, Z., & Shen, Q. (2024) · Journal of Functional Foods · doi:10.1016/j.jff.2024.106179 · Cited by 7
Insulin resistance is positively associated with plasma cathepsin D activity in NAFLD patients
Ding, L., Munck, T. J. I. D., Oligschlaeger, Y., Verbeek, J., Koek, G. H., Houben, T., & Shiri‐Sverdlov, R. (2021) · BioMolecular Concepts · doi:10.1515/bmc-2021-0011 · Cited by 7
Submicron Dispersions of Phytosterols Reverse Liver Steatosis with Higher Efficacy than Phytosterol Esters in a Diet Induced-Fatty Liver Murine Model
Gillet, R., Tomás Cerda, G., Brañes, M. C., & Valenzuela, R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020564 · Cited by 6
Exploring the Gamut of Receptor Tyrosine Kinases for Their Promise in the Management of Non-Alcoholic Fatty Liver Disease
Bhave, S., & Ho, H. K. (2021) · Biomedicines · doi:10.3390/biomedicines9121776 · Cited by 6

Authors: Tarantino, G., Citro, V., & Capone, D.
Affiliations: Federico II University Hospital (IT)
Department of General Medicine, “Umberto I” Hospital, 84014 Nocera Inferiore (Sa), Italy
Care Department of Public Health and Drug-Use, Section of Medical Pharmacology and Toxicology, “Federico II” University, 80131 Naples, Italy
Corresponding author: Tarantino, Giovanni
ORCID: Tarantino, Giovanni
Venue: Journal of Clinical Medicine
Publisher: MDPI AG
Published: 2019-12-19
Volume: 9
Issue: 1
Pages: 15
ISSN: 2077-0383 (ISSN-L)
DOI: 10.3390/jcm9010015
PMC: PMC7019297
OpenAlex: W2995566743
Cited by: 134
References: 123
Citations by year: 2026: 3 · 2025: 6 · 2024: 8 · 2023: 8 · 2022: 27 · 2021: 68 · 2020: 11 · 2019: 2
FWCI: 3.94
Type: journal article
Language: en
Open access: gold
dx.doi.org
Licence: cc-by
creativecommons.org/licenses/by/4.0/ (vor)
Locations: Journal of Clinical Medicine (publishedVersion, cc-by)
Europe PMC (PubMed Central) (publishedVersion, cc-by)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
Keywords: non-alcoholic fatty liver disease, pathogenesis, disease mechanisms, NAFLD therapy, diet and exercise

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Nonalcoholic fatty liver disease: a challenge from mechanisms to therapy.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks